Cargando…

Urine NGAL and KIM-1—Tubular Injury Biomarkers in Long-Term Survivors of Childhood Solid Tumors: A Cross-Sectional Study

The deterioration of renal function after childhood solid tumors treatment is the result of using the intensive multimodal therapy. In recent years, urinary kidney injury molecule-1 (KIM-1) and urinary neutrophil gelatinase-associated lipocalin (NGAL) have been introduced as potential promising biom...

Descripción completa

Detalles Bibliográficos
Autores principales: Latoch, Eryk, Konończuk, Katarzyna, Muszyńska-Rosłan, Katarzyna, Taranta-Janusz, Katarzyna, Wasilewska, Anna, Szymczak, Edyta, Trochim, Justyna, Krawczuk-Rybak, Maryna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866176/
https://www.ncbi.nlm.nih.gov/pubmed/33494327
http://dx.doi.org/10.3390/jcm10030399
_version_ 1783648020245512192
author Latoch, Eryk
Konończuk, Katarzyna
Muszyńska-Rosłan, Katarzyna
Taranta-Janusz, Katarzyna
Wasilewska, Anna
Szymczak, Edyta
Trochim, Justyna
Krawczuk-Rybak, Maryna
author_facet Latoch, Eryk
Konończuk, Katarzyna
Muszyńska-Rosłan, Katarzyna
Taranta-Janusz, Katarzyna
Wasilewska, Anna
Szymczak, Edyta
Trochim, Justyna
Krawczuk-Rybak, Maryna
author_sort Latoch, Eryk
collection PubMed
description The deterioration of renal function after childhood solid tumors treatment is the result of using the intensive multimodal therapy. In recent years, urinary kidney injury molecule-1 (KIM-1) and urinary neutrophil gelatinase-associated lipocalin (NGAL) have been introduced as potential promising biomarkers of early kidney damage. The aim of the present study was to determine whether anticancer treatment has any effect on the concentration of KIM-1 and NGAL and its association with renal impairment in survivors of childhood solid tumors. Sixty patients previously treated for solid tumors were involved in this study. The median time after end of treatment was 8.35 years. Urine KIM-1 and NGAL levels were measured using immunoenzymatic ELISA commercial kits. Higher levels of urine NGAL, KIM-1/cr. (creatinine), and NGAL/cr. ratios were found in comparison with healthy controls (p < 0.0001). Among all subjects, 23% were found to have decreased estimated glomerular filtration rate (eGFR). A strong correlation between KIM-1/cr. and a cumulative dose of ifosfamide was observed (r = 0.865, p < 0.05). In addition, a moderate correlation between NGAL/cr. and a cumulative dose of cisplatin was identified (r = 0.534, p < 0.05). The AUC for KIM-1/cr. was 0.52, whereas NGAL/cr. showed a diagnostic profile describing the AUC of 0.67. Univariable regression showed significant associations between NGAL/cr. ratio and subjects after unilateral nephrectomy (coeff. 63.8, p = 0.007), cumulative dose of cisplatin (coeff. 0.111, p = 0.033), and age at diagnosis (coeff. 3.75, p = 0.023). The multivariable model demonstrated only cumulative dose of cisplatin as an independent factor influence on NGAL/cr. ratio. The results of our study showed increased levels of urine KIM-1 and NGAL many years after completion of the childhood solid tumors treatment, which correlated positively with a cumulative dose of ifosfamide and cisplatin. This study also suggests that unilateral nephrectomy could affect the concentration of the studied biomarkers.
format Online
Article
Text
id pubmed-7866176
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78661762021-02-07 Urine NGAL and KIM-1—Tubular Injury Biomarkers in Long-Term Survivors of Childhood Solid Tumors: A Cross-Sectional Study Latoch, Eryk Konończuk, Katarzyna Muszyńska-Rosłan, Katarzyna Taranta-Janusz, Katarzyna Wasilewska, Anna Szymczak, Edyta Trochim, Justyna Krawczuk-Rybak, Maryna J Clin Med Article The deterioration of renal function after childhood solid tumors treatment is the result of using the intensive multimodal therapy. In recent years, urinary kidney injury molecule-1 (KIM-1) and urinary neutrophil gelatinase-associated lipocalin (NGAL) have been introduced as potential promising biomarkers of early kidney damage. The aim of the present study was to determine whether anticancer treatment has any effect on the concentration of KIM-1 and NGAL and its association with renal impairment in survivors of childhood solid tumors. Sixty patients previously treated for solid tumors were involved in this study. The median time after end of treatment was 8.35 years. Urine KIM-1 and NGAL levels were measured using immunoenzymatic ELISA commercial kits. Higher levels of urine NGAL, KIM-1/cr. (creatinine), and NGAL/cr. ratios were found in comparison with healthy controls (p < 0.0001). Among all subjects, 23% were found to have decreased estimated glomerular filtration rate (eGFR). A strong correlation between KIM-1/cr. and a cumulative dose of ifosfamide was observed (r = 0.865, p < 0.05). In addition, a moderate correlation between NGAL/cr. and a cumulative dose of cisplatin was identified (r = 0.534, p < 0.05). The AUC for KIM-1/cr. was 0.52, whereas NGAL/cr. showed a diagnostic profile describing the AUC of 0.67. Univariable regression showed significant associations between NGAL/cr. ratio and subjects after unilateral nephrectomy (coeff. 63.8, p = 0.007), cumulative dose of cisplatin (coeff. 0.111, p = 0.033), and age at diagnosis (coeff. 3.75, p = 0.023). The multivariable model demonstrated only cumulative dose of cisplatin as an independent factor influence on NGAL/cr. ratio. The results of our study showed increased levels of urine KIM-1 and NGAL many years after completion of the childhood solid tumors treatment, which correlated positively with a cumulative dose of ifosfamide and cisplatin. This study also suggests that unilateral nephrectomy could affect the concentration of the studied biomarkers. MDPI 2021-01-21 /pmc/articles/PMC7866176/ /pubmed/33494327 http://dx.doi.org/10.3390/jcm10030399 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Latoch, Eryk
Konończuk, Katarzyna
Muszyńska-Rosłan, Katarzyna
Taranta-Janusz, Katarzyna
Wasilewska, Anna
Szymczak, Edyta
Trochim, Justyna
Krawczuk-Rybak, Maryna
Urine NGAL and KIM-1—Tubular Injury Biomarkers in Long-Term Survivors of Childhood Solid Tumors: A Cross-Sectional Study
title Urine NGAL and KIM-1—Tubular Injury Biomarkers in Long-Term Survivors of Childhood Solid Tumors: A Cross-Sectional Study
title_full Urine NGAL and KIM-1—Tubular Injury Biomarkers in Long-Term Survivors of Childhood Solid Tumors: A Cross-Sectional Study
title_fullStr Urine NGAL and KIM-1—Tubular Injury Biomarkers in Long-Term Survivors of Childhood Solid Tumors: A Cross-Sectional Study
title_full_unstemmed Urine NGAL and KIM-1—Tubular Injury Biomarkers in Long-Term Survivors of Childhood Solid Tumors: A Cross-Sectional Study
title_short Urine NGAL and KIM-1—Tubular Injury Biomarkers in Long-Term Survivors of Childhood Solid Tumors: A Cross-Sectional Study
title_sort urine ngal and kim-1—tubular injury biomarkers in long-term survivors of childhood solid tumors: a cross-sectional study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866176/
https://www.ncbi.nlm.nih.gov/pubmed/33494327
http://dx.doi.org/10.3390/jcm10030399
work_keys_str_mv AT latocheryk urinengalandkim1tubularinjurybiomarkersinlongtermsurvivorsofchildhoodsolidtumorsacrosssectionalstudy
AT kononczukkatarzyna urinengalandkim1tubularinjurybiomarkersinlongtermsurvivorsofchildhoodsolidtumorsacrosssectionalstudy
AT muszynskarosłankatarzyna urinengalandkim1tubularinjurybiomarkersinlongtermsurvivorsofchildhoodsolidtumorsacrosssectionalstudy
AT tarantajanuszkatarzyna urinengalandkim1tubularinjurybiomarkersinlongtermsurvivorsofchildhoodsolidtumorsacrosssectionalstudy
AT wasilewskaanna urinengalandkim1tubularinjurybiomarkersinlongtermsurvivorsofchildhoodsolidtumorsacrosssectionalstudy
AT szymczakedyta urinengalandkim1tubularinjurybiomarkersinlongtermsurvivorsofchildhoodsolidtumorsacrosssectionalstudy
AT trochimjustyna urinengalandkim1tubularinjurybiomarkersinlongtermsurvivorsofchildhoodsolidtumorsacrosssectionalstudy
AT krawczukrybakmaryna urinengalandkim1tubularinjurybiomarkersinlongtermsurvivorsofchildhoodsolidtumorsacrosssectionalstudy